Curaleaf announces takeover bid plan for Aurora Cannabis
Stamford, Connecticut - Shareholders of Aurora Cannabis Inc. (NASDAQ:ACB) and TSX:ACB may soon face a takeover bid from Curaleaf Holdings Inc. (TSX:CURA) and OTCQX:CURLF, according to a recent press release. The proposed acquisition would see Curaleaf offer 0.3463 of its subordinate voting shares along with US$0.75 in cash for every Aurora share, resulting in a 45% premium based on Aurora's 30-day volume weighted average price of US$2.75.
The deal's value could surpass US$1.5 billion in annual revenue and nearly US$350 million in adjusted EBITDA. Curaleaf initiated discussions with Aurora in June and July 2026 but received no response, leading to the decision to present the offer directly to Aurora shareholders. If approved, the combined company would benefit from at least US$40 million in annual cost synergies, generated by Curaleaf.
The offer is open for 105 days and will not require due diligence or financing conditions. Canaccord Genuity Corp and Dentons LLP will serve as Curaleaf's financial and legal advisors, respectively. The full offer details will be provided in documents filed with Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
